UNSPSC 51102855: Metronidazole/sodium chloride

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AM900. This VA Drug Class (AM900) classifies this compound as belonging to the group ANTI-INFECTIVES, OTHER.

UNSPSC 51102855 Metronidazole/sodium chloride is a Commodity code that covers pharmaceutical products supplied through state and local health procurement channels. Recent state and local opportunities tagged to this code show procurement of antimicrobial and emergency-response medications — including Doxycycline Hyclate and Ciprofloxacin Hydrochloride through cooperative purchasing arrangements, and Naloxone through direct county health procurement. State and local buyers under this code include state health departments and county health authorities using both cooperative purchasing vehicles (such as MMCAP Infuse consortium piggyback agreements) and traditional competitive bidding for pharmaceutical warehouse supply. Work solicited spans bulk pharmaceutical warehouse orders with multi-year contract terms and renewal options, as well as smaller-scale community health procurement with quarterly delivery schedules.

Recent activity appears concentrated in Illinois and Florida. The Illinois Department of Public Health awarded a $2,999,999.11 contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026 for a 12-month initial term with renewal options covering antibiotic tablets in bulk packages. Seminole County, Florida issued an IFB on June 30, 2026 for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to a county health building. The Illinois procurement moved through an Invitation for Bid process as a completed award; the Seminole County procurement called for electronic bid submission through the county's e-Procurement Portal with a two-year initial term and one-year renewal option.